Ticker brief
OTLK OUTLOOK THERAPEUTICS INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$0.6449
1 day
+0.6%
14 days
-14.7%
mkt cap
$175.3M
signals 14d
5
authors 14d
2
crowd 14d
-2.0σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 311% | IV/HV 1.66× (as of 2026-07-10) |
| Skew — 25Δ RR 30d | +0.431 | 25Δ call IV − put IV |
| Net dealer OI (NDOI) | +3.51 elevated | 5-session Δ +0.56 (as of 2026-07-10) |
| OI alarm | quiet | last alarm 2026-07-09 (z=2.1) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-27 · now +0.10 (−1 bearish … +1 bullish)
Who spoke2
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Analytica_X | B | +1.03 | 4 | +0.04 |
| @OzmosiHealth | C | · | 1 | +0.10 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-27 | @OzmosiHealth | +0.10 | Outlook Therapeutics appointed Kevin Lundquist as CFO. | +0.6% | tweet ↗ |
| 2026-08-19 | @Analytica_X | +0.15 | Reports unusually high trading volume in Weave and Outlook Therapeutics. | -6.5% | tweet ↗ |
| 2026-08-18 | @Analytica_X | +0.00 | Summarizes extraordinary volume around company developments while warning about higher financing hurdles. | -7.9% | tweet ↗ |
| 2026-08-18 | @Analytica_X | +0.00 | Reports unusually high trading volumes and associated catalysts for four small-cap stocks. | -7.9% | tweet ↗ |
| 2026-08-17 | @Analytica_X | +0.00 | Reports share volume and relative-volume statistics for four unusually active stocks. | -4.1% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.